The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

Lancet

Volumn 369, Issue 9566, 2007, Pages 1000-1015

  Marson, Anthony G ^a   Al Kharusi, Asya M ^d   Alwaidh, Muna ^e   Appleton, Richard ^b   Baker, Gus A ^a   Chadwick, David W ^a   Cramp, Celia ^f   Cockerell, Oliver C ^g   Cooper, Paul N ^h   Doughty, Julie ^c   Eaton, Barbara ^a   Gamble, Carrol ^a   Goulding, Peter J ⁱ   Howell, Stephen JL ^j   Hughes, Adrian ^k   Jackson, Margaret ^l   Jacoby, Ann ^a   Kellett, Mark ^h   Lawson, Geoffrey R ^m   Leach, John Paul ⁿ   Nicolaides, Paola ^o   Roberts, Richard ^p   Shackley, Phil ^c   Shen, Jing ^c   Smith, David F ^q   Smith, Philip EM ^r   Smith, Catrin Tudur ^a   Vanoli, Alessandra ^c   Williamson, Paula R ^a   more..

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d SOUTHPORT AND ORMSKIRK HOSPITAL NHS TRUST   (United Kingdom)

^e WHISTON HOSPITAL   (United Kingdom)

^f ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

^g ROYAL LONDON HOSPITAL   (United Kingdom)

^h ROYAL BOLTON HOSPITAL   (United Kingdom)

ⁱ LEEDS GENERAL INFIRMARY   (United Kingdom)

^j ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^k ARROWE PARK HOSPITAL   (United Kingdom)

^l ROYAL VICTORIA INFIRMARY   (United Kingdom)

^m SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

ⁿ SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^o GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^p NINEWELLS HOSPITAL   (United Kingdom)

^q WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^r UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; TOPIRAMATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTPATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; COST-BENEFIT ANALYSIS; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 33947241772     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60460-7     Document Type: Article

References (37)

1. Hauser W., and Hesdorffer D. Epilepsy: frequency, causes and consequences (1990), Demos Publications, New York
2. Annegers J., Hauser W., and Elveback L. Remission of seizures and relapse in patients with epilepsy. Epilepsia 20 (1979) 729-737
3. Cockerell O., Johnson A., Sander J., Hart Y., and Shorvon S. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 346 (1995) 140-144
4. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care (2004), National Institute for Clinical Excellence, London Clinical Guideline 20.
5. French J., Kanner A., Bautista J., et al. Efficacy and tolerability of the new antiepileptic drugs i: treatment of new onset epilepsy: report of the therapeutics and technology assessment subcommittee and quality standards subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62 (2004) 1252-1260
6. Marson A., Williamson P., Clough H., Hutton J., and Chadwick D. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia 43 (2002) 505-513
7. Marson A., Kadir Z., and Chadwick D. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 313 (1996) 1169-1174
8. Marson A., Hutton J., Leach J., et al. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review. Epilepsy Res 46 (2001) 259-270
9. Brodie M., Richens A., and Yuen A. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 345 (1995) 476-479
10. Chadwick D., Anhut H., Greiner M., et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology 51 (1998) 1282-1288
11. Dam M., Ekberg R., Loyning Y., Waltimo O., and Jakobsen K. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 3 (1989) 70-76
12. Reunanen M., Dam M., and Yuen A. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res 23 (1996) 149-155
13. Kalviainen R., Aikia M., Saukkonen A., Mervaala E., and Riekkinen Sr. P. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study. Arch Neurol 52 (1995) 989-996
14. Chadwick D. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. Lancet 354 (1999) 13-19
15. Brodie M., Overstall P., and Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 37 (1999) 81-87
16. Brodie M., Bomhof M., Kalviainen R., et al. Double-blind comparison of tiagabine and carbamazepine monotherapy in newly diagnosed epilepsy. Epilepsia 38 suppl 3 (1997) 66-67
17. Brodie M., Wroe S., Dean A., Holdich T., Whitehead J., and Stevens J. Efficacy and safety of remacemide versus carbamazepine in newly diagnosed epilepsy: comparison by sequential analysis. Epilepsy Behav 3 (2002) 140-146
18. Chadwick D., Anhut H., Greiner M., et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology 51 (1998) 1282-1288
19. Privitera M., Brodie M., Mattson R., et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 107 (2003) 165-175
20. Bill P., Vigonius U., Pohlmann H., et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res 27 (1997) 195-204
21. Christe W., Kramer G., Vigonius U., et al. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res 26 (1997) 451-460
22. Guerreiro M., Vigonius U., Pohlmann H., et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 27 (1997) 205-213
23. Steiner T., Dellaportas C., Findley L., et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 40 (1999) 601-607
24. Newer drugs for epilepsy in adults (2004), National Institute for Clinical Excellence, London Technology Appraisal Guidance 76.
25. Newer drugs for epilepsy in children (2004), National Institute for Clinical Excellence, London Technology Appraisal Guidance 79.
26. Gamble C., Williamson P., and Marson A. Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database Syst Rev 1 (2006) CD001031.
27. Medical Research Council. Guidelines for good clinical practice in clinical trials (1998), MRC, London
28. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 (1989) 389-399
29. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22 (1981) 489-501
30. Williamson P., Hutton J., Marson A., and Chadwick D. Individual patient data meta-analyses for time to event outcomes: an example from epilepsy. Control Clin Trials 18 3 suppl 1 (1997) S184
31. Jones B., Jarvis P., Lewis J., and Ebutt A. Trials to assess equivalence; the importance of rigorous methods. BMJ 313 (1996) 36-39
32. Donald M. Implications of non-response for the interpretation of mail questionnaire data. Public Opin Q 24 (1960) 99-114
33. Goyden J. The Silent Minority: non-respondents to sample surveys (1987), Polity Press, Cambridge
34. Messenheimer J., and Guberman A. Rash with lamotrigine: dosing guidelines. Epilepsia 41 (2000) 488
35. Wong I., Mawer G., and Sander J. Factors influencing the incidence of lamotrigine-related skin rash. Ann Pharmacother 33 (1999) 1037-1042
36. Rowan A., Ramsay R., Collins J., et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64 (2005) 1868-1873
37. Brodie M., Chadwick D., Anhut H., et al. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 43 (2002) 993-1000